Noticias y Actividades de Relief Therapeutics
Presencia
Relief Therapeutics es una de las ...
Relief Therapeutics es una empresa que cotiza bajo el símbolo de cotización RLFTY (CH).
Ejecutivos
Ver el organigrama con sus 8 ejecutivos principales
Biografías más buscadas en Relief Therapeutics
- Raghuram Selvaraju, Chairman of the Board
- Vincenzo Gallo, Head of Legal and Compliance
- Christopher Wick, US Country Lead
Crear su alerta
para seguir los movimientos de los ejecutivos en Relief Therapeutics.
Biotecnología
Relief Therapeutics tiene 2.350 competidores entre los que se incluyen Eurofins (Luxemburgo), Lonza (Suiza) y Genus (Reino Unido).
Popular M&A news in Biotecnología
- Transcarent and Accolade have merged (publicado el 9 de abril de 2025)..
- Kashiv BioSciences acaba de anunciar una recaudación de fondos de 150 millones de dólares. (publicado el 7 de abril de 2025).
- Atsena Therapeutics acaba de anunciar una recaudación de fondos de 150 millones de dólares. (publicado el 4 de abril de 2025).
Otros contactos sugeridos en el sector Biotecnología
Noticias
Últimos comunicados de prensa de Relief Therapeutics
- Relief Therapeutics’ Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key U.S. Patent Application Covering PKU GOLIKE®News Detail - Relief Therapeutics Holdings SA
- Relief Therapeutics’ Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key U.S. Patent Application Covering PKU GOLIKE®News Detail - Relief Therapeutics Holdings SA
- Relief Therapeutics’ Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key U.S. Patent Application Covering PKU GOLIKE®News Detail - Relief Therapeutics Holdings SA
- Relief Therapeutics’ Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key U.S. Patent Application Covering PKU GOLIKE®News Detail - Relief Therapeutics Holdings SA
- Relief Therapeutics’ Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key U.S. Patent Application Covering PKU GOLIKE®News Detail - Relief Therapeutics Holdings SA
- Relief Therapeutics’ Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key U.S. Patent Application Covering PKU GOLIKE®News Detail - Relief Therapeutics Holdings SA
- Relief Therapeutics’ Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key U.S. Patent Application Covering PKU GOLIKE®News Detail - Relief Therapeutics Holdings SA
- Relief Therapeutics’ Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key U.S. Patent Application Covering PKU GOLIKE®News Detail - Relief Therapeutics Holdings SA
- Relief Therapeutics’ Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key U.S. Patent Application Covering PKU GOLIKE®News Detail - Relief Therapeutics Holdings SA
- Relief Therapeutics’ Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key U.S. Patent Application Covering PKU GOLIKE®News Detail - Relief Therapeutics Holdings SA
- View more press releases Close
Redes sociales sobre Relief Therapeutics
- Relief Therapeutics en Wikipedia, Google News y Yahoo Finance
- Relief Therapeutics en LinkedIn, Twitter y YouTube
